PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Integra LifeSciences Holdings Corporation (IART)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS4579852082
CUSIP457985208
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$2.27B
EPS$0.84
PE Ratio34.39
PEG Ratio0.83
Revenue (TTM)$1.54B
Gross Profit (TTM)$982.03M
EBITDA (TTM)$383.57M
Year Range$27.18 - $51.12
Target Price$44.40
Short %3.85%
Short Ratio3.86

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Integra LifeSciences Holdings Corporation

Popular comparisons: IART vs. HOLX, IART vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Integra LifeSciences Holdings Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


700.00%800.00%900.00%1,000.00%1,100.00%1,200.00%1,300.00%December2024FebruaryMarchAprilMay
777.77%
815.73%
IART (Integra LifeSciences Holdings Corporation)
Benchmark (^GSPC)

S&P 500

Returns By Period

Integra LifeSciences Holdings Corporation had a return of -33.66% year-to-date (YTD) and -42.45% in the last 12 months. Over the past 10 years, Integra LifeSciences Holdings Corporation had an annualized return of 6.33%, while the S&P 500 had an annualized return of 10.64%, indicating that Integra LifeSciences Holdings Corporation did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-33.66%7.50%
1 month-14.78%-1.61%
6 months-25.45%17.65%
1 year-42.45%26.26%
5 years (annualized)-11.34%11.73%
10 years (annualized)6.33%10.64%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-7.81%-8.07%-3.96%-17.72%
2023-5.84%8.98%11.13%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IART is 4, indicating that it is in the bottom 4% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of IART is 44
Integra LifeSciences Holdings Corporation(IART)
The Sharpe Ratio Rank of IART is 22Sharpe Ratio Rank
The Sortino Ratio Rank of IART is 66Sortino Ratio Rank
The Omega Ratio Rank of IART is 44Omega Ratio Rank
The Calmar Ratio Rank of IART is 1010Calmar Ratio Rank
The Martin Ratio Rank of IART is 11Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Integra LifeSciences Holdings Corporation (IART) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


IART
Sharpe ratio
The chart of Sharpe ratio for IART, currently valued at -1.17, compared to the broader market-2.00-1.000.001.002.003.004.00-1.17
Sortino ratio
The chart of Sortino ratio for IART, currently valued at -1.55, compared to the broader market-4.00-2.000.002.004.006.00-1.55
Omega ratio
The chart of Omega ratio for IART, currently valued at 0.76, compared to the broader market0.501.001.500.76
Calmar ratio
The chart of Calmar ratio for IART, currently valued at -0.69, compared to the broader market0.002.004.006.00-0.69
Martin ratio
The chart of Martin ratio for IART, currently valued at -1.91, compared to the broader market-10.000.0010.0020.0030.00-1.91
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.17, compared to the broader market-2.00-1.000.001.002.003.004.002.17
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.11, compared to the broader market-4.00-2.000.002.004.006.003.11
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.65, compared to the broader market0.002.004.006.001.65
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.41, compared to the broader market-10.000.0010.0020.0030.008.41

Sharpe Ratio

The current Integra LifeSciences Holdings Corporation Sharpe ratio is -1.17. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Integra LifeSciences Holdings Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-1.17
2.17
IART (Integra LifeSciences Holdings Corporation)
Benchmark (^GSPC)

Dividends

Dividend History

Integra LifeSciences Holdings Corporation granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM202320222021202020192018201720162015
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$6.37

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%18.80%

Monthly Dividends

The table displays the monthly dividend distributions for Integra LifeSciences Holdings Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2015$6.37$0.00$0.00$0.00$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-62.30%
-2.41%
IART (Integra LifeSciences Holdings Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Integra LifeSciences Holdings Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Integra LifeSciences Holdings Corporation was 87.75%, occurring on Jan 15, 1999. Recovery took 634 trading sessions.

The current Integra LifeSciences Holdings Corporation drawdown is 62.30%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.75%May 1, 1996685Jan 15, 1999634Jul 23, 20011319
-63.34%Jun 6, 2007443Mar 9, 2009540Apr 28, 2011983
-63.02%Apr 28, 2021755Apr 26, 2024
-58.57%Feb 14, 2002180Oct 30, 2002253Oct 31, 2003433
-55.64%May 11, 2011169Jan 10, 2012740Dec 18, 2014909

Volatility

Volatility Chart

The current Integra LifeSciences Holdings Corporation volatility is 11.73%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%December2024FebruaryMarchAprilMay
11.73%
4.10%
IART (Integra LifeSciences Holdings Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Integra LifeSciences Holdings Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items